The Future of the European Medicines Agency
It could be argued that the European Medicines Agency is a bell weather for the plight of the Brexit negotiations. The Canary Wharf based agency is at the centre of much wooing from EU member states while the UK...
EU Authorised Representatives Post Brexit: What Happens Next?
The UK’s impending departure from the EU will necessitate a change in designated EU Authorised Representatives for companies that are currently using a UK based authorised representative at present. This will cause considerable upheaval and disruption to companies using such...
Download ‘The Road Ahead’ – Our Latest Brexit Whitepaper
Editor’s Note: ‘The Road Ahead’ whitepaper was first published in January 2017. Much has happened with Brexit since then. You can stay up to date on all of the Acorn Regulatory Brexit content here. Now that the British Prime Minister...
Lancaster House Speech & What It Means for Life Sciences
British Prime Minister Theresa May’s Lancaster House speech was much anticipated by many sectors, including the life sciences sector in the UK and further afield. In this brief PDF we look at the implications of her speech for the life...
Most Read Life Sciences Brexit News Stories on AcornRegulatory.com in 2016
We appear to have become accustomed to the phrase ‘no one foresaw this happening’. The term certainly applies to those of us taken by surprise in the early hours of June 24th 2016 when the announcement was made that the...
Brexit & Regulatory Affairs – The UK Is Heading for the Exit
In an extract from our second Brexit whitepaper, we look at the impact of Brexit on regulatory affairs and issues such as the future of the European Medicines Agency, Pharmacovigilance and Brexit and much more.
How Will The UK Life Sciences Sector Address Post Brexit Skills Shortages?
The UK pharmaceutical sector employs in excess of seventy thousand people. The structure of a Brexit will have significant impact on them and the industry that they work in. For now, there is a firm belief that the UK will...
Who Will Host The European Medicines Agency?
For those of us working in the sector, the future location of the European Medicines Agency has been a consistent topic of conversation since the outcome of the Brexit vote became known.
Download Our Latest Brexit Whitepaper – Heading for the Exit
Where Next for the European Medicines Agency? In our second Brexit whitepaper, we are looking at the implications of the decision to leave on one of the most ‘mission-critical’ agencies of the EU – the European Medicines Agency. The future...
The Implications of Brexit for the Life Sciences Sector
The implications of Brexit are still being felt. Politically, the decision has triggered a chain of events that none of us could have ever foreseen. Now, with a new Prime Minister in Downing Street and three leading ‘Brexiteers’ appointed to offices...
By using this website, you agree to our
cookie policy.
Close